BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9366314)

  • 1. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
    Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
    J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate salts for preventing and treating calcium containing kidney stones in adults.
    Phillips R; Hanchanale VS; Myatt A; Somani B; Nabi G; Biyani CS
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010057. PubMed ID: 26439475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Wuermser LA; Poindexter J; Pak CY
    J Clin Pharmacol; 1998 Nov; 38(11):1035-41. PubMed ID: 9824785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
    Pak CY; Koenig K; Khan R; Haynes S; Padalino P
    J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Pak CY
    Am J Kidney Dis; 1999 Jul; 34(1):107-13. PubMed ID: 10401023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
    Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate and renal calculi: new insights and future directions.
    Pak CY
    Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
    Koenig K; Padalino P; Alexandrides G; Pak CY
    J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
    Odvina CV; Mason RP; Pak CY
    Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects.
    Vongpatanasin W; Peri-Okonny P; Velasco A; Arbique D; Wang Z; Ravikumar P; Adams-Huet B; Moe OW; Pak CYC
    Am J Cardiol; 2016 Sep; 118(6):849-853. PubMed ID: 27448942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study.
    Lee YH; Huang WC; Tsai JY; Huang JK
    J Urol; 1999 May; 161(5):1453-7. PubMed ID: 10210371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.
    Lindberg J; Harvey J; Pak CY
    J Urol; 1990 Feb; 143(2):248-51. PubMed ID: 2299712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
    Wuermser LA; Reilly C; Poindexter JR; Sakhaee K; Pak CY
    Kidney Int; 2000 Feb; 57(2):607-12. PubMed ID: 10652038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of meal on the physiological and physicochemical actions of potassium citrate.
    Pak CY; Oh MS; Baker S; Morris JS
    J Urol; 1991 Sep; 146(3):803-5. PubMed ID: 1875495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.